Ajlouni K, Martinson D R, Hagen T C
Diabetes. 1975 Jul;24(7):633-6. doi: 10.2337/diab.24.7.633.
The effect of hyperglycemia on the growth hormone response to oral L-dopa (500 mg.) was assessed in eight normal and eight insulin-dependent diabetic subjects. A peak growth hormone response of 21.0 +/- 4.0 ng./ml. (mean +/- S.E.M.), significantly above baseline (p less than 0.01), was achieved in the normal group following oral L-dopa. Glucose concentrations did not change and were approximately 80 mg./100 ml. throughout. Administration of 100 gm. oral glucose with the L-dopa, or thirty minutes thereafter, totally suppressed the growth hormone response in all eight and six of the subjects, respectively. A peak growth hormone response of 20.0 "/- 1.7 ng./ml. (mean +/- S.E.M.), significantly above baseline (p less than 0.001), was obtained in eight nonobese, insulin-dependent diabetics, in spite of prevailing hyperglycemia (mean plasma glucose 243-258 mg./100 ml.) throughout the test. Endogenous hyperglycemia was achieved in these patients by lessening the usual strict adherence to plasma glucose control for the purpose of the study. These results suggest an abnormality in the hypothalamus or pituitary of diabetic subjects allowing growth hormone responsiveness in spite of hyperglycemia.
在8名正常受试者和8名胰岛素依赖型糖尿病受试者中,评估了高血糖对口服左旋多巴(500毫克)后生长激素反应的影响。正常组口服左旋多巴后,生长激素反应峰值达到21.0±4.0纳克/毫升(平均值±标准误),显著高于基线水平(p<0.01)。整个过程中血糖浓度未发生变化,约为80毫克/100毫升。与左旋多巴同时给予100克口服葡萄糖,或在其后30分钟给予,分别完全抑制了所有8名和6名受试者的生长激素反应。在8名非肥胖胰岛素依赖型糖尿病患者中,尽管在整个测试过程中存在持续性高血糖(平均血浆葡萄糖243 - 258毫克/100毫升),仍获得了20.0±1.7纳克/毫升(平均值±标准误)的生长激素反应峰值,显著高于基线水平(p<0.001)。为了该研究目的,通过减少这些患者通常对严格控制血糖的坚持程度实现了内源性高血糖。这些结果表明,糖尿病患者下丘脑或垂体存在异常,尽管存在高血糖,但仍允许生长激素产生反应。